日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases

检测转移过程中循环游离 DNA 中的乳腺癌干细胞基因突变

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-019-05374-x
Zhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, Joe E Ensor, Helen J Huang, Joan Albanell, Dong S Choi, Ana Lluch, Yi Liu, Federico Rojo, Helen Wong, Eduardo Martínez-Dueñas, Ángel Guerrero-Zotano, Zhi-Min Shao, Jorge G Darcourt, Gordon B Mills, Bhuvanesh Dave, Jenny C Chang
发育与干细胞
肿瘤
乳腺癌
干细胞
发表日期：2019
文献求助 收藏

Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models

评估以抗 PD-1 为基础的疗法对人源化小鼠模型中移植的三阴性乳腺癌患者异种移植肿瘤的效果

期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-018-1037-4
Roberto R Rosato, Daniel Dávila-González, Dong Soon Choi, Wei Qian, Wen Chen, Anthony J Kozielski, Helen Wong, Bhuvanesh Dave, Jenny C Chang
肿瘤
乳腺癌
发表日期：2018
文献求助 收藏

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors

哺乳动物雷帕霉素靶标抑制在神经内分泌肿瘤患者治疗中的关键作用

期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.742
Alexandria T Phan, Bhuvanesh Dave
神经
肿瘤
mTOR
发表日期：2016
文献求助 收藏

Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer

激活 PIK3CA 突变可诱导基底样乳腺癌中的表皮生长因子受体 (EGFR)/细胞外信号调节激酶 (ERK) 旁分泌信号轴

期刊:Molecular & Cellular Proteomics
影响因子:6.1
doi:10.1074/mcp.M115.049783
Christian D Young, Lisa J Zimmerman, Daisuke Hoshino, Luigi Formisano, Ariella B Hanker, Michael L Gatza, Meghan M Morrison, Preston D Moore, Corbin A Whitwell, Bhuvanesh Dave, Thomas Stricker, Neil E Bhola, Grace O Silva, Premal Patel, Dana M Brantley-Sieders, Maren Levin, Marina Horiates, Norma A
信号转导
肿瘤
乳腺癌
其它细胞
WB
MAPK/ERK
发表日期：2015
文献求助 收藏

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer

抑制iNOS作为三阴性乳腺癌的一种新的有效靶向治疗方法

期刊:Breast Cancer Research
影响因子:6.1
doi:10.1186/s13058-015-0527-x
Sergio Granados-Principal, Yi Liu, Maria L Guevara, Elvin Blanco, Dong Soon Choi, Wei Qian, Tejal Patel, Angel A Rodriguez, Joseph Cusimano, Heidi L Weiss, Hong Zhao, Melissa D Landis, Bhuvanesh Dave, Steven S Gross, Jenny C Chang
肿瘤
乳腺癌
WB
发表日期：2015
文献求助 收藏

Design and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cells

针对乳腺肿瘤起始细胞的逐层 siRNA 纳米载体的设计及体外评估

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0091986
Hamsa Jaganathan, Sucharita Mitra, Srimeenakshi Srinivasan, Bhuvanesh Dave, Biana Godin
肿瘤
乳腺癌
其它细胞
发表日期：2014
文献求助 收藏

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

靶向 RPL39 和 MLF2 可通过抑制一氧化氮合酶信号传导减少乳腺癌的肿瘤发生和转移

期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:
doi:10.1073/pnas.1320769111
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, Stephen Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, Ke-Da Yu, Zhimin Shao, Xiaoxian Li, Michael Gilcrease, Zhao Lai, Yidong Chen, Tim H-M Huang, Haifa Shen, Xuewu Liu, Mauro Ferrari, Ming Zhan, Stephen T C Wong, Muthiah Kumaraswami, Vivek Mittal
信号转导
肿瘤
乳腺癌
发表日期：2014
文献求助 收藏

Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors

曲妥珠单抗耐药细胞依赖于 HER2-PI3K-FoxO-survivin 轴，对 PI3K 抑制剂敏感

期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-12-2440
Anindita Chakrabarty, Neil E Bhola, Cammie Sutton, Ritwik Ghosh, María Gabriela Kuba, Bhuvanesh Dave, Jenny C Chang, Carlos L Arteaga
免疫
细胞生物学
其它细胞
PI3K/Akt
发表日期：2013
文献求助 收藏